146 related articles for article (PubMed ID: 34064793)
1. Does Trypsin Oral Spray (Viruprotect
Huijghebaert S; Vanham G; Van Winckel M; Allegaert K
Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064793
[TBL] [Abstract][Full Text] [Related]
2. Comment on Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect
Davison G
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612951
[TBL] [Abstract][Full Text] [Related]
3. Reply to Davison, G. Comment on "Huijghebaert et al. Does Trypsin Oral Spray (Viruprotect
Huijghebaert S; Vanham G; Van Winckel M; Allegaert K
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612954
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
[TBL] [Abstract][Full Text] [Related]
5. Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study.
Lindberg BF; Nelson I; Ranstam J; Riker DK
PLoS One; 2023; 18(1):e0279204. PubMed ID: 36652464
[TBL] [Abstract][Full Text] [Related]
6. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ColdZyme® Mouth Spray on prevention of upper respiratory tract infections in a boy with primary immunodeficiency: a case report.
Clarsund M; Blom U; Gardulf A
J Med Case Rep; 2016 Oct; 10(1):302. PubMed ID: 27799071
[TBL] [Abstract][Full Text] [Related]
8. Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
Davison G; Perkins E; Jones AW; Swart GM; Jenkins AR; Robinson H; Dargan K
Eur J Sport Sci; 2021 May; 21(5):771-780. PubMed ID: 32419645
[TBL] [Abstract][Full Text] [Related]
9. ColdZyme® protects airway epithelia from infection with BA.4/5.
Zaderer V; Dichtl S; Bellmann Weiler R; Lass Flörl C; Posch W; Wilflingseder D
Respir Res; 2022 Oct; 23(1):300. PubMed ID: 36316674
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
13. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry.
Kim Y; Jang G; Lee D; Kim N; Seon JW; Kim YH; Lee C
Arch Virol; 2022 Feb; 167(2):441-458. PubMed ID: 35079901
[TBL] [Abstract][Full Text] [Related]
14. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
[TBL] [Abstract][Full Text] [Related]
15. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
[TBL] [Abstract][Full Text] [Related]
16. Drug-Free Nasal Spray as a Barrier against SARS-CoV-2 and Its Delta Variant: In Vitro Study of Safety and Efficacy in Human Nasal Airway Epithelia.
Fais F; Juskeviciene R; Francardo V; Mateos S; Guyard M; Viollet C; Constant S; Borelli M; Hohenfeld IP
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409423
[TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.
De Boeck I; Cauwenberghs E; Spacova I; Gehrmann T; Eilers T; Delanghe L; Wittouck S; Bron PA; Henkens T; Gamgami I; Simons A; Claes I; Mariën J; Ariën KK; Bakokimi D; Loens K; Jacobs K; Ieven M; Bruijning-Verhagen P; Delputte P; Coenen S; Verhoeven V; Lebeer S
Microbiol Spectr; 2022 Oct; 10(5):e0168222. PubMed ID: 36154666
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
19. Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
Lin Y; Yue S; Yang Y; Yang S; Pan Z; Yang X; Gao L; Zhou J; Li Z; Hu L; Tang J; Wu Q; Lei S; Tian Q; Wang Y; Hao Y; Xu L; Huang Q; Zhu B; Chen Y; Chen X; Ye L
Clin Infect Dis; 2023 Feb; 76(3):e336-e341. PubMed ID: 35666466
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
